1. Data WOHWLC-i-P: Global tuberculosis report 2013. In Book Global tuberculosis report, 2013. Edited by Global tuberculosis report 2013. Switzerland: World Health Organization (WHO); 2013.
2. WHO: Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti- Tuberculosis Drug Resistance Surveillance Report No. 3. 2004, WHO, Geneva
3. Forget EJ, Menzies D: Adverse reactions to first-line antituberculosis drugs. Expert Opin Drug Saf. 2006, 5: 231-249. 10.1517/14740338.5.2.231.
4. Marra F, Marra CA, Bruchet N, Richardson K, Moadebi S, Elwood RK, Fitzgerald JM: Adverse drug reactions associated with first-line anti-tuberculosis drug regimens. Int J Tuberc Lung Dis. 2007, 11: 868-875.
5. Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR: An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006, 174: 935-952. 10.1164/rccm.200510-1666ST.